doi: 10.1007/s10661-016-5331-2 3 AlturiqiA
2 Side effects are the leading cause of malnourishment on GLP-1
Why the brand-name trumps all To that end, when there arent any insurance or financial pressures steering the decision, Phoenix and Raven generally recommend brand-name Ozempic as the first-line option as Broussenko believes it has a long track record, a robust supply chain, and a level of familiarity that removes guesswork for both patients and providers
Searches were conducted using combinations of keywords and Medical Subject Headings (MeSH) terms related to incretin-based therapies and obesity, including GLP-1 receptor agonists, dual agonists, triple agonists, liraglutide, semaglutide, tirzepatide, mazdutide, retatrutide, adolescent obesity, and pediatric obesity
Finding the Right Balance for Your Goals If your primary goal is general wellness and healthy ageing, a lower daily dose of both may be sufficient